Clinical Trials in Dallas

Showing 10641-10660 of 17,468 trials

Resuscitative Endocrinology: Single-dose Clinical Uses for Estrogen-Traumatic Hemorrhagic Shock (RESCUE - Shock)

NCT00973102

Based on encouraging results from animal studies, the investigators hypothesize that early administration of IV Premarin® in patients with hemorrhagic shock will safely reduce secondary injury, and improve survival.

Hemorrhagic Shock

University of Texas Southwestern Medical Center50 participantsStarted Jul 2009

Dallas, Texas, United States • Dallas, Texas, United States

COMPLETEDPhase 1< 1 mile

Clinical Trial of ARQ 761 in Advanced Solid Tumors

NCT01502800

Primary Objective: To determine the safety, tolerability and recommended Phase 2 dose (RP2D) of ARQ 761 administered intravenously. Secondary Objectives: To determine the pharmacokinetic profile of ARQ 761 To assess the preliminary anti-tumor activity of aRQ 761

Solid Tumors

University of Texas Southwestern Medical Center91 participantsStarted Dec 2011

Dallas, Texas, United States

Resuscitative Endocrinology: Single-dose Clinical Uses for Estrogen-Traumatic Hemorrhagic Shock (RESCUE - Shock)

Clinical Trial of ARQ 761 in Advanced Solid Tumors

Find Trials by Condition in Dallas

Non-Interventional F-Two Isoprostane Trial (NIFTI)

Apneic Oxygenation With a Nasal Cannula in the Obese and Morbidly Obese Surgical Patient

A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis

A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation

Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy

A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

Genetic Analysis of Hereditary Prostate Cancer

Novel Endoluminal Clinical TreAtment of Reflux

Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

The Effect of BMS-986195 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients

Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event